These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38074770)

  • 1. Early disruptions to syringe services programs during the Russian invasion of Ukraine.
    Nikitin BM; Bromberg DJ; Pykalo I; Ivasiy R; Islam Z; Altice FL
    Front Public Health; 2023; 11():1229057. PubMed ID: 38074770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of COVID-19 on New York State's Drug User Health Hubs and syringe service programs: a qualitative study.
    Ude M; Behrends CN; Kelly S; Schackman BR; Clear A; Goldberg R; Gelberg K; Kapadia SN
    Harm Reduct J; 2023 Feb; 20(1):12. PubMed ID: 36732773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of harm reduction service utilization and HIV incidence among people who inject drugs in Ukraine: A two-part latent profile analysis.
    Ompad DC; Wang J; Dumchev K; Barska J; Samko M; Zeziulin O; Saliuk T; Varetska O; DeHovitz J
    Int J Drug Policy; 2017 May; 43():7-15. PubMed ID: 28160736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Has resourcing of non-governmental harm-reduction organizations in Ukraine improved HIV prevention and treatment outcomes for people who inject drugs? Findings from multiple bio-behavioural surveys.
    Trickey A; Semchuk N; Saliuk T; Sazonova Y; Varetska O; Walker JG; Lim AG; Stone J; Vickerman P
    J Int AIDS Soc; 2020 Aug; 23(8):e25608. PubMed ID: 32851812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with obtaining sterile syringes from pharmacies among persons who inject drugs in 20 US cities.
    Zlotorzynska M; Weidle PJ; Paz-Bailey G; Broz D;
    Int J Drug Policy; 2018 Dec; 62():51-58. PubMed ID: 30359873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Access to HIV, Viral Hepatitis, and Substance Use Disorder Treatment/Overdose Prevention Services: A Qualitative Analysis of Syringe Service Programs (SSPs) Serving Rural PWID.
    Carnes NA; Asher AK; Bohm MK; Bessler PA
    Subst Use Misuse; 2021; 56(13):1933-1940. PubMed ID: 34353216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Were Needles Everywhere?: Differing Views on Syringe Waste and Disposal Associated With Needs-Based Syringe Services Programs Among Community Partners and Persons Who Inject Drugs.
    Hershow RB; Love Pieczykolan L; Worthington N; Adams M; McDonald R; Wilson S; McBee S; Balleydier S; Curran KG
    Subst Use Misuse; 2024; 59(8):1174-1181. PubMed ID: 38509704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Housing-based syringe services programs to improve access to safer injecting equipment for people who inject drugs in Vancouver, Canada: a spatially oriented qualitative study.
    Chayama KL; Ng C; Fleming T; Small W; Sue KL; McNeil R
    Harm Reduct J; 2023 Sep; 20(1):126. PubMed ID: 37679789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors that influence enrollment in syringe services programs in rural areas: a qualitative study among program clients in Appalachian Kentucky.
    Ibragimov U; Cooper KE; Batty E; Ballard AM; Fadanelli M; Gross SB; Klein EM; Lockard S; Young AM; Cooper HLF
    Harm Reduct J; 2021 Jun; 18(1):68. PubMed ID: 34193165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barriers to engaging people who use drugs in harm reduction services during the COVID-19 pandemic: A mixed methods study of syringe services program perspectives.
    Austin EJ; Corcorran MA; Briggs ES; Frost MC; Behrends CN; Juarez AM; Frank ND; Healy E; Prohaska SM; LaKosky PA; Kapadia SN; Perlman DC; Schackman BR; Jarlais DCD; Williams EC; Glick SN
    Int J Drug Policy; 2022 Nov; 109():103825. PubMed ID: 35977459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Harm reduction via online platforms for people who use drugs in Russia: a qualitative analysis of web outreach work.
    Davitadze A; Meylakhs P; Lakhov A; King EJ
    Harm Reduct J; 2020 Dec; 17(1):98. PubMed ID: 33298081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding the public health consequences of suspending a rural syringe services program: a qualitative study of the experiences of people who inject drugs.
    Allen ST; Grieb SM; O'Rourke A; Yoder R; Planchet E; White RH; Sherman SG
    Harm Reduct J; 2019 May; 16(1):33. PubMed ID: 31109339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A qualitative study of service engagement and unmet needs among unstably housed people who inject drugs in Massachusetts.
    Hassan R; Roland KB; Hernandez B; Goldman L; Evans KN; Gaul Z; Agnew-Brune C; Buchacz K; Fukuda HD
    J Subst Abuse Treat; 2022 Jul; 138():108722. PubMed ID: 35067399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Service utilization and cost of implementing a comprehensive HIV prevention and care program among people who inject drugs in Delhi, India.
    Sebastian MP; Dasgupta A; Saraswati LR; Singh A; Sharma V; Madan I; Tun W; Pulerwitz J; Thior I; Sarna A
    Harm Reduct J; 2017 Jun; 14(1):38. PubMed ID: 28615077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of the COVID-19 pandemic on people who inject drugs accessing harm reduction services in an rural American state.
    Thakarar K; Kohut M; Hutchinson R; Bell R; Loeb HE; Burris D; Fairfield KM
    Harm Reduct J; 2022 Jul; 19(1):80. PubMed ID: 35869523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mixed methods exploration of injection drug use risk behaviors and place-based norms in Ukraine.
    Owczarzak J; Slutsker JS; Mazhnaya A; Tobin K; Kiriazova T
    J Subst Use Addict Treat; 2023 Nov; 154():209135. PubMed ID: 37544509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Qualitative Analysis of Barriers to Accessing HIV Prevention Services During an HIV Outbreak among Persons who Inject Drugs in West Virginia.
    Hershow RB; Worthington N; Adams M; McDonald R; Wilson S; McBee S; Balleydier S; Curran KG
    AIDS Behav; 2024 Feb; 28(2):669-681. PubMed ID: 38165598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Program Adaptations to Provide Harm Reduction Services During the COVID-19 Pandemic: A Qualitative Study of Syringe Services Programs in the U.S.
    Frost MC; Sweek EW; Austin EJ; Corcorran MA; Juarez AM; Frank ND; Prohaska SM; LaKosky PA; Asher AK; Broz D; Jarlais DCD; Williams EC; Glick SN
    AIDS Behav; 2022 Jan; 26(1):57-68. PubMed ID: 34110506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in Injection Risk Behaviors among People Who Inject Drugs and the Impact of Harm Reduction Programs in Ukraine, 2007-2013.
    Makarenko I; Ompad DC; Sazonova Y; Saliuk T; DeHovitz J; Gensburg L
    J Urban Health; 2017 Feb; 94(1):104-114. PubMed ID: 28097615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV risk and prevention among clients of a delivery-based harm reduction service during an HIV outbreak among people who use drugs in northern rural Minnesota, USA.
    Palayew A; Knudtson K; Purchase S; Clark S; Possehl L; Healy E; Deutsch S; McKnight CA; Des Jarlais D; Glick SN
    Harm Reduct J; 2023 Aug; 20(1):102. PubMed ID: 37533085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.